Ihuman Inc (IH)

iHuman Inc. is a Beijing-based company founded in 1996 that develops intellectual growth products for children and other users in China and international markets. Its offerings include a range of interactive and self-directed digital apps, such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Coding, and related products under the iHuman, bekids, and Aha brands. The company also provides books, interactive learning materials, and smart devices designed to support speaking, critical thinking, independent reading, and creativity. In addition, iHuman offers Cosmicrew, a 3D comedic adventure animation series. The listed security is an American depositary receipt representing common stock on the NYSE.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-IH
$1.77
55.3% Upside
Bargain
Not available
Not available
Fair
7.4%
December 17, 2026
5.4x
0.4x
0.5x
58.269 M
-96.263 M
2.7%
27.5%
10.7
41.0%
63.2%
Valuation • Fair Value

Ihuman Inc (NYSE-IH) Fair Value by Valuation Model

Review the available estimates for Ihuman Inc (NYSE-IH), including Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.77

Estimated upside of 55.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$2.38

Classic Ben Graham valuation formula reference.

DDM Fair Value

$1.39

Dividend discount model valuation reference.

Comps Fair Value

$1.90

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Ihuman Inc (NYSE-IH) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Ihuman Inc (NYSE-IH)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

112.9 M

Current operating scale indicator.

Revenue Forecast

120.4 M

Forward revenue estimate.

EBITDA

5.993 M

Current operating profitability reference.

EBITDA Forecast

13.428 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ihuman Inc (NYSE-IH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ihuman Inc (NYSE-IH)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.27

No elevated caution signal from this screen.

Altman Z-Score

10.7

Relatively strong balance-sheet zone.

FCF / Net Income

63.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ihuman Inc (NYSE-IH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ihuman Inc (NYSE-IH)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 17, 2026

Days to Earnings

86

Dividend Yield

7.4%

Current income yield reference.

Payout Ratio

41.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Ihuman Inc (NYSE-IH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ihuman Inc (NYSE-IH) Stock Forecast & Technical Outlook

Review Ihuman Inc (NYSE-IH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Ihuman Inc (NYSE-IH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Ihuman Inc (NYSE-IH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Ihuman Inc (NYSE-IH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Ihuman Inc (NYSE-IH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Ihuman Inc (NYSE-IH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ihuman Inc (NYSE-IH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Ihuman Inc (NYSE-IH) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Ihuman Inc (NYSE-IH) Stock FAQ

Data-supported answers about Ihuman Inc (NYSE-IH), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.77
Estimated upside 55.3%
Valuation Rating
Undervalued
Estimated upside of 55.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Ihuman Inc (NYSE-IH) is $1.77. This implies an estimated upside of 55.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 55.3% versus the current market price.

The current financial health read for Ihuman Inc (NYSE-IH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ihuman Inc (NYSE-IH) is December 17, 2026.

Based on the current data, dividend yield is 7.4%.

The current P/E ratio listed for Ihuman Inc (NYSE-IH) is 5.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ihuman Inc is 58.269 M.

The current enterprise value listed for Ihuman Inc is -96.263 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ihuman Inc is NYSE-IH, and the stock is listed on NYSE.

Ihuman Inc (NYSE-IH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Ihuman Inc is 2.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ihuman Inc is 27.5%. Free float helps investors understand how much of the share base is available for public trading.